Skip Navigation Links
 
 
ExSAR Corporation is a clinical developmental stage company dedicated to identifying, developing and commercializing small-molecule therapeutics for protein misfolding diseases. Protein misfolding is a prominent feature of a diverse number of diseases, examples of which include Tay-Sachs, Gaucher, Alzheimer's and Parkinson's. ExSAR utilizes their platform technology to screen lead compounds for their ability to prevent protein misfolding and restore protein function.
EXR-101
Adult Tay-Sachs
and Sandhoff Disease
Patient Enrollment
More...
ExSAR
H-D/Ex Technology

How our unique
technology works.
More...
Applications
Epitope Mapping
Bioequivalence
Target Validation
More...
Home   |   About Us   |   Therapeutic Focus   |   Technology   |   News and Publications   |   Careers   |   Contact Us
ExSAR is a trademark of ExSAR Corporation. Content © 2008 ExSAR Corporation. Terms of Use © 2008
11 Deer Park Drive, Suite 103   |   Monmouth Junction, New Jersey 08852   |   Phone: (732) 438-6500   |   Fax: (732) 438-1919
Optimized for resolutions of 1024 x 768 or higher with Microsoft Internet Explorer 6.0 or later
Web Site Designed and Maintained by Stonehouse Media Incorporated©